<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Brazil May Reject Gilead AIDS Patent</title>
	<atom:link href="http://www.pharmalot.com/2008/04/brazil-may-reject-gilead-aids-patent/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/04/brazil-may-reject-gilead-aids-patent/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 18:44:10 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Aids &#187; Blog Archive &#187; Brazil May Reject Gilead AIDS Patent</title>
		<link>http://www.pharmalot.com/2008/04/brazil-may-reject-gilead-aids-patent/#comment-271658</link>
		<dc:creator>Aids &#187; Blog Archive &#187; Brazil May Reject Gilead AIDS Patent</dc:creator>
		<pubDate>Thu, 10 Apr 2008 19:26:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/brazil-may-reject-gilead-aids-patent/#comment-271658</guid>
		<description>[...] Continue Reading    &#160;Posted on: Thursday, April 10, 2008 at 1:53 pm &#160;Uncategorized.  You can follow any responses to this entry through the RSS 2.0 feed.  You can leave a response, or trackback from your own site. [...]</description>
		<content:encoded><![CDATA[<p>[...] Continue Reading    &nbsp;Posted on: Thursday, April 10, 2008 at 1:53 pm &nbsp;Uncategorized.  You can follow any responses to this entry through the RSS 2.0 feed.  You can leave a response, or trackback from your own site. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.148 seconds -->

